lovastatin has been researched along with Cancer of Mouth in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bisen, PS; Bundela, S; Sharma, A | 1 |
| Chang, JZ; Cheng, SJ; Deng, YT; Kuo, MY; Yeh, CC | 1 |
2 other study(ies) available for lovastatin and Cancer of Mouth
| Article | Year |
|---|---|
Potential Compounds for Oral Cancer Treatment: Resveratrol, Nimbolide, Lovastatin, Bortezomib, Vorinostat, Berberine, Pterostilbene, Deguelin, Andrographolide, and Colchicine.
Topics: Administration, Oral; Algorithms; Antineoplastic Agents; Berberine; Bortezomib; Colchicine; Databases, Pharmaceutical; Databases, Protein; Diterpenes; Humans; Hydroxamic Acids; Limonins; Lovastatin; Models, Statistical; Mouth Neoplasms; Predictive Value of Tests; Resveratrol; Rotenone; Stilbenes; Support Vector Machine; Vorinostat | 2015 |
Arecoline stimulated Cyr61 production in human gingival epithelial cells: inhibition by lovastatin.
Topics: Areca; Arecoline; Blotting, Western; Carcinoma, Squamous Cell; Cell Line, Tumor; Cysteine-Rich Protein 61; Epithelial Cells; Gene Expression Regulation, Neoplastic; Gingiva; Humans; Lovastatin; Male; Mouth Neoplasms; Plant Extracts; Reverse Transcriptase Polymerase Chain Reaction; Up-Regulation | 2011 |